结直肠手术中吲哚菁绿荧光血管造影预防吻合口漏的成本分析
本研究从医院支付方角度,采用决策分析模型比较结直肠切除是否常规使用吲哚菁绿荧光血管造影(ICG-FA)评估吻合口灌注的成本。基于基础假设(无ICG-FA时漏率8.6%,ICG-FA降低漏率的OR为0.46,ICG-FA成本250美元,无需再手术的漏增量成本9,934.50美元),常规使用ICG-FA可节省成本,每例节省192.22美元。单因素敏感性分析显示,当吻合口漏成本高于5,616.29美元、ICG-FA成本低于634.44美元、无ICG-FA时漏率高于4.9%或OR低于0.69时,ICG-FA均节省成本。作者结论为常规使用ICG-FA是成本节省策略,但证据质量低,需要前瞻性随机对照试验。
要点
- 基于基础假设,常规ICG-FA每例节省192.22美元。
- ICG-FA成本低于634.44美元时常规使用可节省成本。
- 无ICG-FA时漏率高于4.9%时ICG-FA可节省成本。
核心结论
- 基于最佳 available 证据和最保守的基础假设,结直肠手术常规使用ICG-FA被发现在成本上是节省的。
- 由于证据提示漏率降低,常规使用ICG-FA是一种优势策略。
- 然而,总体证据质量低,明确需要前瞻性随机对照试验。
研究设计与样本
- 从医院支付方角度进行的成本分析。
- 开发了决策分析模型,考虑两种情景:不使用ICG-FA的结直肠切除和使用ICG-FA进行吻合口灌注评估的切除。
- 模型纳入ICG试剂、荧光血管造影设备、手术、吻合口漏的成本以及使用和不使用ICG-FA的漏率。
- 所有输入数据来源于近期发表的文献。
主要发现
- 在基础假设下(无ICG-FA时漏率8.6%,ICG-FA降低漏率的OR为0.46,即漏率4.8%相对于8.6%的基础值,ICG-FA成本250美元,无需再手术的漏增量成本9,934.50美元),常规使用ICG-FA节省成本。
- 单因素敏感性分析中,若吻合口漏成本超过5,616.29美元、ICG-FA成本低于634.44美元、无ICG-FA时漏率高于4.9%或ICG-FA降低漏率的OR低于0.69,则常规使用ICG-FA节省成本。
- 使用ICG-FA每例节省192.22美元。
临床怎么用
- 从医院支付方角度看,在基础假设条件下,结直肠手术中常规使用ICG-FA进行吻合口灌注评估可节省成本。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Indocyanine green, near infrared, fluorescence angiography (ICG-FA) is increasingly adopted in colorectal surgery for intraoperative tissue perfusion assessment to reduce anastomotic leakage rates. However, the economic impact of this intervention has not been investigated. This study is a cost analysis of the routine use of ICG-FA in colorectal surgery from the hospital payer perspective. METHODS: A decision analysis model was developed for colorectal resections considering two scenarios: resection without using ICG-FA and resection with intraoperative ICG-FA for anastomotic perfusion assessment. Incorporated into the model were the costs of ICG agent, fluorescence angiography equipment, surgery, anastomotic leak, and the leak rates with and without ICG-FA. All input data were derived from recent publications. RESULTS: The routine use of ICG-FA for colorectal anastomosis is cost saving when cost analysis is performed using the following base case assumptions: 8.6% leak rate without ICG-FA, odds ratio of 0.46 for reduction of leakage with ICG-FA (4.8% leak rate relative to 8.6% base case), cost of ICG-FA of $250, and incremental cost of leak, not requiring reoperation, of $9,934.50. In one-way sensitivity analyses, routine use of ICG-FA was cost saving if the cost of an anastomotic leak is more than $5616.29, the cost of ICG-FA is less than $634.44, the leak rate (without ICG-FA) is higher than 4.9%, or the odds ratio for reduction of leak with ICG-FA is less than 0.69. There is a per-case saving of $192.22 with the use of ICG-FA. CONCLUSION: Using the best available evidence and most conservative base case values, routine use of ICG-FA in colorectal surgery was found to be cost saving. Since the evidence suggests there is a reduction in leak rate, the routine use of ICG-FA is a dominating strategy. However, the overall quality of evidence is low and there is a clear need for prospective, randomized controlled trials.
引用
- Liu RQ, Elnahas A, Tang E, et al. Cost analysis of indocyanine green fluorescence angiography for prevention of anastomotic leakage in colorectal surgery. Surg Endosc. 2022. PMID: 35290507. doi:10.1007/s00464-022-09166-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。